scholarly journals Effect of Sodium Bicarbonate in Kidney Transplant Recipients With Chronic Metabolic Acidosis

2019 ◽  
Vol 5 (7) ◽  
pp. e464
Author(s):  
Kevin Schulte ◽  
Jodok Püchel ◽  
Katrin Schüssel ◽  
Christoph Borzikowsky ◽  
Ulrich Kunzendorf ◽  
...  
2021 ◽  
Vol 36 (Supplement_1) ◽  
Author(s):  
Pedro Henrique Imenez Silva ◽  
Anna Wiegand ◽  
Arezoo Daryadel ◽  
Ariana Gaspert ◽  
Giancarlo Russo ◽  
...  

Abstract Background and Aims Metabolic acidosis is a common event in kidney transplant recipients and has been associated to a higher risk of graft loss and mortality. In patients with CKD and acidosis, alkali therapy ameliorating acidosis appears to protect kidney function. However, it is still poorly understood how acidosis causes the detrimental effects to kidney graft function and how alkali therapy would interact with these mechanisms. Here we aim to identify transcriptomic alterations in kidney transplant recipients without metabolic acidosis in comparison to patients with metabolic acidosis with and without alkali therapy. Moreover, we examined immunolocalization of key proteins involved in acid-base base regulation in biopsies from these patients. Method We obtained 22 biopsies of patients 4-6 years after kidney transplantation. Among these patients, nine were not acidotic (serum [HCO3-] ≥ 22 mM), nine had acidosis ([HCO3-] < 22 mM), and four had acidosis and received sodium bicarbonate (alkali therapy) fully correcting acidosis. Age, immunosuppressive drugs, time after transplantation, and eGFR were not statistically different between groups. RNA was extracted from biopsies and RNAseq was performed. Immunohistochemistry was performed for key proteins involved in the renal regulation of acid-base balance. Additionally, a control group of 6 non-transplanted healthy kidneys was included in the histology analysis. Results RNAseq analysis revealed 40 genes differentially expressed between acidosis and no acidosis groups. While most of the genes tended to be recovered by alkali therapy, only three fully recovered with bicarbonate supplementation (p-value < 0.05 and log2(fold change) above 0.5). These genes were KCNJ15 (Kir4.2), SHMT1, and ACADSB. Renal localization of the genes was determined using single-cell RNA sequencing data (Ransick et al., Developmental Cell, 2019, doi.org/10.1016/j.devcel.2019.10.005). Most of the genes were expressed in the proximal tubule and were organized in the model shown in Figure 1A. Several of these genes participate in cell metabolism, such as beta-oxidation, and iron, folate, and methionine metabolism. Moreover, the K+-channel Kir4.2 regulates the activity of the electrogenic sodium bicarbonate cotransporter 1 (NBCe1, SLC4A4) and ammoniagenesis in renal proximal tubules. Immunofluorescence analysis showed that NBCe1 expression in proximal tubules was strongly reduced in patients who developed acidosis and was partially recovered in patients who received alkali therapy (Figure 1B). In type B intercalated cells, a similar pattern was observed for Pendrin (SLC26A4). No alteration in the expression of GDH (GLUD1), AE1 (SLC4A1), AQP2, CA2, RhCG (SLC42A3), and B1 subunit of the H+ATPase (ATP6V1B1) was observed in kidneys of treated or untreated patients with acidosis. Conclusion Kidney transplant recipients suffering from metabolic acidosis show distinct expression pattern of genes involved in cell metabolism and acid-base transport.


2016 ◽  
Vol 28 (6) ◽  
pp. 1886-1897 ◽  
Author(s):  
Seokwoo Park ◽  
Eunjeong Kang ◽  
Sehoon Park ◽  
Yong Chul Kim ◽  
Seung Seok Han ◽  
...  

2020 ◽  
Vol 35 (Supplement_3) ◽  
Author(s):  
Anna Wiegand ◽  
Arezoo Daryadel ◽  
Pedro Henrique Imenez da Silva ◽  
Ariana Gaspert ◽  
Rudolf Peter Wuthrich ◽  
...  

Abstract Background and Aims Metabolic acidosis (MA) is a frequent complication of chronic kidney disease and an independent risk factor for kidney disease progression and mortality. MA is highly prevalent after kidney transplantation (12%-58%)(1). However, there are scarcely any data available on the underlying pathomechanisms and in particular molecular mechanisms involved in metabolic acidosis after kidney transplantation. Thus, we wanted to investigate the expression of key acid base transport proteins in kidney biopsies of kidney transplant recipients with and without metabolic acidosis. Method We evaluated 22 kidney transplant biopsies including 9 biopsies from kidney transplant recipients (KTR) with MA, nine biopsies from KTRs without MA (control) and four biopsies from KTRs with MA that were consequently subjected to alkali therapy (Alkali therapy). Immunofluorescence staining was used to identify key renal acid-base transport proteins. Additionally, six control kidneys were analyzed. Immunofluorescence staining was used to identify key renal acid-base transport proteins along the nephron. In addition, RNA extraction and full RNA sequencing analysis of all biopsies –where available- was performed. Results In the proximal tubule, we observed reduced immunostaining for the sodium bicarbonate cotransporter NBCe1 (SLC4A4) in the MA group compared to the control and alkali group, whereas the alkali group demonstrated the strongest staining of all three groups. In the distal nephron, expression of the chloride/bicarbonate exchanger Pendrin (SLC26A4) and the B1 subunit of the V-ATPase (ATP6V1B1) were markedly stronger in the alkali and control group compared to the MA group. Expression of other acid base proteins such as Renal ammonia transporter RhCG (SLC42A3), Carbonic Anhydrase II, Glutamate dehydrogenase, anion exchanger AE1 (SLC4A1) and the B2 subunit of the V-ATPase (ATP6V1B2) showed no difference among all groups. Interestingly, the B2 subunit was absent in the proximal tubule in transplant biopsies of all groups. In kidney biopsies of transplant recipients with metabolic acidosis RNA abundance of NBCe1, CAII and Pendrin was lower while RhCG and B1 RNA counts were not different when compared to recipients without metabolic acidosis. Conclusion Our data demonstrate altered protein and mRNA expression of several key acid base transporters in kidney biopsies of transplant recipients with metabolic acidosis. Treatment with alkali may have the potential to reverse or prevent these changes in renal allografts after transplantation.


2020 ◽  
Vol 35 (Supplement_3) ◽  
Author(s):  
Shuzo Kaneko ◽  
Joichi Usui ◽  
Kazuhiro Takahashi ◽  
Tomokazu Kimura ◽  
Akio Hoshi ◽  
...  

Abstract Background and Aims Hyperchloremic metabolic acidosis (HCMA) due to renal tubular acidosis is a common complication in kidney transplant recipients(KTR). Potential renal dysfunction, rejection, ischemia, persistent hyperparathyroidism, calcineurin inhibitors (CNIs), etc. have been identified as causes but have not been fully proven, and whether HCMA is a determinant of poor graft prognosis in KTR is still controversial. The purpose of this study is to elucidate the actual mechanism of HCMA in KTR. Method HCMA was defined as follows: i) simple strong ion difference (SID) Na-CL, which is the most dominant metabolic factor in physicochemical approach for acid-base balance, is 34 or less, or â…±) the alkalizing drugs have been started after the KT to correct HCMA. And all the cases of having diarrhea from mycophenolate mofetil(MMF), and gastroenterocolitis from cytomegalovirus infection were excluded. The study group consisted of 47 KTRs who underwent living-kidney transplantation(KT) at our hospital as well as a control group of 43 of the matched donors. Among them, a total of 26 KTRs received the renal hemodynamic studies which were based on urinary clearance of inulin and para-aminohippuric acid 1year after KT. 1) The incidence of HCMA in KTR at 3 months(3m) and 1 year(1y) after KT were examined. 2) To elucidate factors related to HCMA in KTR at 1y, we comprehensively examined factors and compared HCMA groups with non-HCMA groups; donor and recipient background (gender, age, body size), immunological factors, information on transplant surgery, salt and protein intake, effective buffering factors for extracellular body fluids such as albumin and hemoglobin, serum calcium and phosphate concentrations and their ratios, administration of renin-angiotensin system inhibitors and diuretics,Tac trough level and Banff score of each histopathological lesion in 1y biopsy. As for the 26 KTRs who received the renal hemodynamic studies, glomerular filtration rate (GFR), renal plasma flow (RPF), filtration fraction(FF) (GFR/RPF) and pre-/post-glomerular vascular resistance (pre-/postVR) calculated from the Gomez' equations were also analyzed. Results 1) The incidence of HCMA in the KTR at 3m was 51% (24/47), which was much higher than the 6.9% (3/43) in those donors (p<0.001), and the range of odds ratios (vs donor) adjusted by the background factors (age,gender, estimated GFR, albumin and hemoglobin) was 6.7-15.7 (p=0.0001-0.001). The incidence of HCMA in KTR at 1y decreased to 34%. 2)The univariate analysis of HCMA in KTR at 1y compared with non-HCMA showed an increase in RPF (p= 0.016), a decrease in post-VR (p= 0.003), and a decrease in FF (p= 0.0001), suggesting an increase in post-glomerular peritubular blood flow. In addition, the aah lesion score, an indicator of CNI vasculopathy, was also significantly higher in the HCMA (p = 0.015). There was no difference in Tac trough levels between HCMA and nonHCMA, and no independent factors were found by multivariate analysis. All cases with HCMA were classified into low post-VR (Fig.1). Furthermore, in low post-VR alone (n= 15), the Tac trough level at 1y was significantly higher in the HCMA (p= 0.002) (Fig.2). Conclusion In kidney transplant recipients, increased post-glomerular peritubular blood flow is a key condition for the development of CNI-induced renal tubular acidosis. The presence of HCMA suggests that it is probably not a serious condition, but rather a desirable hemodynamic state, however, more attention should be paid not to elevate CNI concentration levels in such conditions.


Diabetes ◽  
1988 ◽  
Vol 37 (9) ◽  
pp. 1247-1252 ◽  
Author(s):  
J. A. Van der Vliet ◽  
X. Navarro ◽  
W. R. Kennedy ◽  
F. C. Goetz ◽  
J. J. Barbosa ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document